Abstract
ALZHEIMER'S disease is characterized by the extracellular deposition in the brain and its blood vessels of insoluble aggregates of the amyloid β-peptide (Aβ), a fragment, of about 40 amino acids in length, of the integral membrane protein β-amyloid precursor protein (β-APP)1. The mechanism of extracellular accumulation of αβ in brain is unknown and no simple in vitro or in vivo model systems that produce extracellular Aβ have been described. We report here the unexpected identification of the 4K (Mr 4,000) Aβ and a truncated form of Aβ (∼3K) in media from cultures of primary cells and untransfected and β-APP-transfected cell lines grown under normal conditions. These peptides were immunoprecipitated readily from culture medium by Aβ-specific antibodies and their identities confirmed by sequencing. The con-cept that pathological processes are responsible for the production of Aβ must now be reassessed in light of the observation that Aβ is produced in soluble form in vitro and in vivo2 during normal cellular metabolism. Further, these findings provide the basis for using simple cell culture systems to identify drugs that block the formation or release of Aβ, the primary protein constituent of the senile plaques of Alzheimer's disease.
Similar content being viewed by others
References
Kang, J. et al. Nature 325, 733–736 (1987).
Seubert, P. et al. Nature 359, 325–327 (1992).
Selkoe, D. et al. Proc. natn. Acad. Sci. U.S.A. 85, 7341–7345 (1988).
Tamaoka, A., Kalaria, R. N., Lieberburg, I. & Selkoe, D. J. Proc. natn. Acad. Sci. U.S.A. 89, 1345–1349 (1992).
Weidemann, A. et al. Cell. 57, 115–126 (1989).
Oltersdorf, T. et al. J. biol. Chem. 265, 4492–4497 (1990).
Esch, F. et al. Science 248, 1122–1124 (1990).
Sisodia, S. S., Koo, E. H., Beyreuther, K., Unterbeck, A. & Price, D. L. Science 248, 492–495 (1990).
Greenberg, S. M., Rosenthal, D. S., Greeley, T. A., Tantravahi, R. & Handin, R. I. Blood 72, 1968–1977 (1988).
Podlisny, M. B., Tolan, D. & Selkoe, D. J. Am. J. Path. 139, 1423–1435 (1991).
Estus, S. et al. Science 255, 726–728 (1992).
Nordstedt, C. et al. Proc. natn. Acad. Sci. U.S.A. 88, 8910–8914 (1991).
Golde, T., Esius, S., Younkin, L. H., Selkoe, D. J. & Younkln, S. G. Science 255, 728–730 (1992).
Haass, C., Koo, E. H., Mellon, A., Hung, A. Y. & Selkoe, D. J. Nature 357, 500–503 (1992).
Gabuzda, D. H., Busciglio, J. & Yankner, B. A. Neurology (abstr.) 42, 304 (1992).
Joachim, C. L., Mori, H. & Selkoe, D. J. Nature 341, 226–230 (1989).
Selkoe, D. J. Neurobiol. Aging 10, 387–395 (1989).
Mori, H., Takio, K., Ogawara, M. & Selkoe, D. J. J. biol. Chem. 267, 17082–17086 (1992).
Haass, C., Hung, A. Y. & Selkoe, D. J. J. Neurosci. 11, 3783–3793 (1991).
Anderson, J. P., Chen, Y., Kim, K. S. & Robakis, N. K. J. Neurochem. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haass, C., Schlossmacher, M., Hung, A. et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325 (1992). https://doi.org/10.1038/359322a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/359322a0
- Springer Nature Limited
This article is cited by
-
The advent of Alzheimer treatments will change the trajectory of human aging
Nature Aging (2024)
-
Emerging diagnostics and therapeutics for Alzheimer disease
Nature Medicine (2023)
-
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Nature (2023)
-
Alzheimer’s disease – the journey of a healthy brain into organ failure
Molecular Neurodegeneration (2022)
-
Isoproterenol, an adrenergic β receptor agonist, induces metallothionein synthesis followed by canceling amyloid β1-42-induced neurodegeneration
BioMetals (2022)